Drugs / BCG-10
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04648800 Comparator | Jul → Dec 2020 | COVID-19, tuberculosis | Hanna Czajka | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG-10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04648800 ↗ |
| Modality | Vaccine | “The BCG-10 anti-tuberculosis vaccine” NCT04648800 ↗ |